Dayer, Jean-Michel

CCR5 is characteristic of Th1 lymphocytes

Loetscher, P., Uguccioni, M., Bordoli, L., Baggiolini, M., Moser, B., Chizzolini, C., & Dayer, J.-M. (1998) · Nature

Chemokine receptors and signalingT-cell and B-cell Immunology

Cited by 866

How Cytokine Networks Fuel Inflammation: Toward a cytokine-based disease taxonomy

Schett, G., Elewaut, D., McInnes, I. B., Dayer, J.-M., & Neurath, M. F. (2013) · Nature Medicine

Cytokine Signaling Pathways and InteractionsPsoriasis: Treatment and Pathogenesis

Cited by 406

IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin?

Meier, C. A., Bobbioni, E., Gabay, C., Assimacopoulos-Jeannet, F., Golay, A., & Dayer, J.-M. (2002) · The Journal of Clinical Endocrinology & Metabolism

Adipokines, Inflammation, and Metabolic DiseasesRegulation of Appetite and Obesity

Cited by 287

Decreased Fat Mass in Interleukin-1 Receptor Antagonist–Deficient Mice

Somm, E., Henrichot, E., Pernin, A., Juge-Aubry, C. E., Muzzin, P., Dayer, J.-M., Nicklin, M. J. H., & Meier, C. A. (2005) · Diabetes

Adipokines, Inflammation, and Metabolic DiseasesRegulation of Appetite and Obesity

Cited by 114

Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents

Somm, E., Cettour-Rose, P., Asensio, C., Charollais, A., Klein, M., Theander-Carrillo, C., Juge-Aubry, C. E., Dayer, J. M., Nicklin, M. J. H., Meda, P., et al. (2006) · Diabetologia

Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and Metabolism

Cited by 111